Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 893 of 6351
-
Immunotherapy boost before surgery shows promise against head and neck cancer
Disease control OngoingThe objective of research is to evaluate the efficacy and safety of Toripalimab combined with AP regimen in the treatment of resectable locally advanced head and neck squamous cell carcinoma.122 patients were randomly divided into two groups: the test group (Toripalimab combined …
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
MRNA vaccine technology takes on advanced cancers
Disease control Recruiting nowThe primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab or ipilimumab and nivolumab.
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug combo shows promise for AML patients
Disease control CompletedThe goal of this clinical research study is to evaluate the safety and efficacy of Azacytidine in combination with Venetoclax in patients with newly diagnosed fit acute myeloid leukemia.
Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could less radiation be just as effective for some head and neck cancers?
Disease control OngoingCurrent radiotherapy guidelines and consensus statements uniformly recommend elective region irradiation (ERI) as the standard strategy for nasopharyngeal carcinoma (NPC). However, given the scarcity of skip-metastasis, the improved assessment accuracy of nodal involvement, and t…
Phase 3 • Sponsor: Yi Junlin • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Ear zaps during heart attack may shield the heart from damage
Disease control CompletedAt the moment, the invasive strategy for the infarct-associated coronary artery in patients with ST-segment elevation myocardial infarction (STEMI) necessary to save the myocardium and reduce the size of the necrosis zone remains the leading one. However, despite the high efficie…
Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
A new talk therapy aims to tackle both insomnia and PTSD in veterans
Symptom relief Recruiting nowThis randomized trial will compare a novel treatment, Acceptance of the Behavioral Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I) among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder. ABC-I combines the b…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
A hospital bedside workout: the new weapon against Age-Related decline?
Prevention CompletedThis study aims to examine 1) if multicomponent exercise interventions (including both mobility and strengthening exercises) have effects on physical function compared to usual care in older adults, and 2) if a comprehensive multicomponent exercise program is more effective than …
Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Zapping aggression: could a headset tame impulsive outbursts?
Disease control Recruiting nowAggressive behaviours are highly prevalent among people with developmental disabilities, both in community and inpatient or residential settings, with adverse consequences for the individuals involved and others. Some predictive factors, particularly impulsivity, are dynamic with…
Sponsor: Dr. Najat Khalifa • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new daily pill offer safer Long-Term schizophrenia control?
Disease control Stopped earlyThe primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug cocktail aims to stop liver cancer recurrence
Disease control CompletedA Trial to Evaluate the Efficacy and Safety of Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation.
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Diabetes drug shows promise for kidney and heart health in Non-Diabetic patients
Disease control CompletedThe goal of this clinical trial is to learn if the drug dapagliflozin (an SGLT2 inhibitor) can help protect the kidneys, improve anemia, and support heart health in adults with chronic kidney disease (CKD) who do not have diabetes. The main questions it aims to answer are: Does …
Phase 3 • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Radiation boost may help CAR-T cells wipe out stubborn lymphoma
Disease control Recruiting nowThis is a single-arm single center study to prospectively evaluate the safety and efficacy of ultra-fraction radiotherapy bridging CAR-T therapy in relapsed/refractory diffuse large b cell lymphoma
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a DNA test predict who will respond to cancer immunotherapy?
Disease control Completedimmunotherapy,gastric cancer,rectal cancer,biomark
Phase 2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New pill shows promise for rare lung cancer mutations
Disease control Recruiting nowThis is a Phase 2b, multicenter, open-label study to evaluate the safety and efficacy of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Non-resistant Uncommon EGFR Mutations Only, Including L861Q, G719X, and/or S768I)
Phase 2 • Sponsor: Teligene US • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for rare bleeding disorder: emicizumab trial launches
Disease control OngoingThis is a phase II multicenter open-label, single-arm prospective study to evaluate the efficacy of prophylactic emicizumab administered on a scheduled basis to prevent bleeds in patients with acquired hemophilia A (AHA).
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Strawberries as medicine? trial tests whether the fruit can calm inflammation and boost insulin response
Disease control CompletedThe proposed research is designed to extend previous research findings building on the knowledge of strawberries as fruits that support a healthy immune and vascular system. The proposed research leverages a recently funded proposal by the USDA to study in greater depth inflammat…
Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for breast cancer patients with brain tumors: drug combo trial underway
Disease control Recruiting nowThis is a multi-site, global, open-label study that includes a phase 1b evaluation of elacestrant in combination with abemaciclib in women and men with brain metastases from estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER-2) negative breast cancer. …
Phase 1/2 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
New hope for rare muscle disease: baricitinib trial aims to cut steroid use
Disease control Recruiting nowDermatomyositis (DM) is a rare and disabling condition with an important impairment of quality of life and possible life-threatening complications. Treatment is based on high doses of corticosteroids but this exposes patients to adverse events (cardiovascular mortality, glucocor…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New Triple-Drug cocktail aims to shrink metastatic breast tumors
Disease control Recruiting nowThis is a phase 2, open-label, singled-arm clinical trial determining efficacy of combination therapy with anastrozole, fulvestrant and abemaciclib in subjects with breast cancer. These are subjects who are newly diagnosed advanced or metastatic hormone receptor positive breast c…
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Diet over drugs: eHealth trial aims to remit type 2 diabetes
Disease control Recruiting nowOverweight patients with type 2 diabetes are offered a total diet replacement with the goal of weight loss and diabetes remission. Study participants are randomised to eHealth follow-up or face-to-face follow-up, but the dietary advice is the same in both groups. A healthy contro…
Sponsor: Umeå University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC